CClinicalTrials.gg
CompletedNCT03859960Updated Sep 4, 2020Results posted

The Effects of Spasticity on Glucose Metabolism in Individuals With Spinal Cord Injury

An observational study in Spinal Cord Injuries, sponsored by Fatih Sultan Mehmet Training and Research Hospital. Completed. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-09-04.

Sponsored by Fatih Sultan Mehmet Training and Research Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
33
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Muscle atrophy may occur in individuals with spinal cord injury (SCI) as a result of diminished physical activity and alterations in glucose metabolism and body composition may be seen. In a few studies, it has been suggested that spasticity may have a positive impact on glucose metabolism by preventing muscle atrophy and alterations in body composition in individuals with motor complete SCI. Investigators aimed to assess the effects of spasticity on glucose metabolism and body composition in participants with complete and incomplete SCI.

Read the detailed description

Investigators plan a prospective clinical trial. Participants with SCI were included to study if times from injury were at least one year. Participants had an AIS grades of A-D with spasticity. We evaluated that participants with AIS A and B SCI were motor complete group, AIS C and D SCI were motor incomplete group. Spasticity was assessed with Modified Ashworth Scale (MAS) and spasms were assessed with Penn Spasm Frequency Scale (PSFS). Hip adductor and extensor spasticity, knee extensor and flexor spasticity and ankle plantar flexor spasticity were assessed by using MAS. Body composition was measured by dual-energy x-ray absorptiometry. All participants underwent a 75 gram (g) oral glucose tolerance test (OGTT). Insulin sensitivity was assessed by calculating Matsuda index and HOMA-IR. Investigators assessed the effects of spasticity on glucose metabolism and body composition in participants with SCI.

02

Conditions studied

  • Spinal Cord Injuries

Keywords

  • Body composition
  • glucose
  • spasticity
  • spinal cord injury
03

In context

Muscle Spasticity

703 studies on the registry are indexed under Muscle Spasticity; 148 are open to participants now.

This study's enrollment of 33 is below the median of 60 across 162 observational studies indexed under Muscle Spasticity.

Browse Muscle Spasticity studies →

Lead sponsor

Fatih Sultan Mehmet Training and Research Hospital is the lead sponsor of 118 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Individuals with SCI were included to study if they were 18-65 years old and times from injury were at least one year.

Inclusion criteria

  • Spinal cord injury AIS A,B,C,D

Exclusion criteria

Exclusion Criteria:

  • Other central nervous system diseases
  • Significant complications that affect spasticity
  • Joint contracture
  • Diabetes mellitus
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
33 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testbody composition

    fat mass % (FM%) and fat-free mass (FFM%)% of arms, legs, trunk, android, gynoid and total body

    Also known as: dual-energy absorptiometry (DXA),

  • Diagnostic testglucose, insulin, glycohemoglobin

    In the morning after 12 hours overnight fast, all individuals underwent a 75 gram (g) oral glucose tolerance test (OGTT). Blood samples were taken before loading glucose and then 30, 60, 90 and 120 minutes after taking glucose solution in order to measure serum glucose and insulin levels. Glycohemoglobin (HbA1c) was measured in blood samples taken before the OGTT. We calculated the Matsuda index and Homeostasis model assessment index (HOMA-IR) using glucose and insulin levels.

    Also known as: fasting blood glucose, insulin, glycohemoglobin

06

What researchers measure

Primary outcomes

  1. Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Insulin Resistance

    Modified Ashworth Scale is used to assess muscle spasticity on a 6-point scale. 0: No increase in muscle tone 4: Affected part(s) is (are) rigid in flexion or extension. Higher scores mean a worse outcome. HOMA index was used to evaluate insulin resistance. HOMA index is a simple, and inexpensive method used for evaluating insulin sensitivity. In most of the studies, values \>2.7 were accepted as insulin resistance. HOMA-IR was calculated by using fasting plasma glucose (mg/dL) X fasting insulin (uIU/mL) /405 formula. Pearson correlation was used to calculate the correlation coefficient (r).

    Time frame: One day

  2. Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Insulin Sensitivity

    We used the Matsuda index to assess insulin sensitivity. Matsuda index was calculated 10.000/square root (Fasting plasma glucose x fasting plasma insulin) x (mean OGTT glucose concentration X mean OGTT insulin concentration) formula. Higher scores mean better. Modified Ashworth Scale is used to assess muscle spasticity on a 6-point scale. 0: No increase in muscle tone 4: Affected part(s) is (are) rigid in flexion or extension. Higher scores mean a worse outcome. Pearson correlation was used to calculate the correlation coefficient (r).

    Time frame: One day

  3. Correlation Between Penn Spasm Frequency Scale and Insulin Resistance

    Penn Spasm Frequency Scale is used to assess spasms. This scale is a 5-point scale. Higher scores mean a worse outcome. HOMA index is a simple, and inexpensive method used for evaluating insulin sensitivity. In most of the studies, values \>2.7 were accepted as insulin resistance. HOMA-IR was calculated by using fasting plasma glucose (mg/dL) X fasting insulin (uIU/mL) /405 formula. Pearson correlation was used to calculate the correlation coefficient (r).

    Time frame: One day

  4. Correlation Between Penn Spasm Frequency Scale and Insulin Sensitivity

    We used the Matsuda index to assess insulin sensitivity. Matsuda index was calculated 10.000/square root (Fasting plasma glucose x fasting plasma insulin) x (mean OGTT glucose concentration X mean OGTT insulin concentration) formula. Higher scores mean better. Penn Spasm Frequency Scale is used to assess spasms. This scale is a 5-point scale. Higher scores mean a worse outcome. Pearson correlation was used to calculate the correlation coefficient (r).

    Time frame: One day

  5. Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Total Body Fat-Free Mass%

    The body composition of the individuals was measured by dual-energy absorptiometry (DXA) device. Modified Ashworth Scale is used to assess muscle spasticity on a 6-point scale. 0: No increase in muscle tone 4: Affected part(s) is (are) rigid in flexion or extension. Higher scores mean a worse outcome. Pearson correlation was used to calculate correlation coefficient.

    Time frame: One day

  6. Correlation Between Penn Spasm Frequency Scale and Total Body Fat-Free Mass%

    The body composition of the individuals was measured by dual-energy absorptiometry (DXA) device. Penn Spasm Frequency Scale is used to assess spasms. This scale is a 5-point scale. Higher scores mean a worse outcome. Pearson correlation was used to calculate the correlation coefficient (r).

    Time frame: One day

07

Results

Posted Sep 4, 2020

Participant flow

Individuals with SCI recruited from the inpatient rehabilitation unit of an education and research hospital. Recruitment began in September 2014 and was completed in May 2018.

Participant flow — Overall Study
MilestoneMotor Complete GroupMotor Incomplete Group
Started1419
Completed1419
Not completed00

Outcome measures

PrimaryCorrelation Between Knee Flexor Muscle Modified Ashworth Scale and Insulin Resistance

Modified Ashworth Scale is used to assess muscle spasticity on a 6-point scale. 0: No increase in muscle tone 4: Affected part(s) is (are) rigid in flexion or extension. Higher scores mean a worse outcome. HOMA index was used to evaluate insulin resistance. HOMA index is a simple, and inexpensive method used for evaluating insulin sensitivity. In most of the studies, values \>2.7 were accepted as insulin resistance. HOMA-IR was calculated by using fasting plasma glucose (mg/dL) X fasting insulin (uIU/mL) /405 formula. Pearson correlation was used to calculate the correlation coefficient (r).

Time frame:
One day
Reported as:
Number · correlation coefficient
Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Insulin Resistance
correlation coefficientMotor CompleteMotor Incomplete
Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Insulin Resistance-0.6920.23
Statistical analysis
  • Motor Complete · Pearson correlation test · p = 0.006
  • Motor Incomplete · Pearson correlation test · p = 0.23 (p\<0.05 was considered statisticaly significant.)
PrimaryCorrelation Between Knee Flexor Muscle Modified Ashworth Scale and Insulin Sensitivity

We used the Matsuda index to assess insulin sensitivity. Matsuda index was calculated 10.000/square root (Fasting plasma glucose x fasting plasma insulin) x (mean OGTT glucose concentration X mean OGTT insulin concentration) formula. Higher scores mean better. Modified Ashworth Scale is used to assess muscle spasticity on a 6-point scale. 0: No increase in muscle tone 4: Affected part(s) is (are) rigid in flexion or extension. Higher scores mean a worse outcome. Pearson correlation was used to calculate the correlation coefficient (r).

Time frame:
One day
Reported as:
Number · correlation coefficient
Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Insulin Sensitivity
correlation coefficientMotor CompleteMotor Incomplete
Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Insulin Sensitivity0.797-0.084
Statistical analysis
  • Motor Complete · Pearson correlation test · p = 0.001 (p\<0.05 was considered statisticaly significant.)
  • Motor Incomplete · Pearson correlation test · p = 0.731
PrimaryCorrelation Between Penn Spasm Frequency Scale and Insulin Resistance

Penn Spasm Frequency Scale is used to assess spasms. This scale is a 5-point scale. Higher scores mean a worse outcome. HOMA index is a simple, and inexpensive method used for evaluating insulin sensitivity. In most of the studies, values \>2.7 were accepted as insulin resistance. HOMA-IR was calculated by using fasting plasma glucose (mg/dL) X fasting insulin (uIU/mL) /405 formula. Pearson correlation was used to calculate the correlation coefficient (r).

Time frame:
One day
Reported as:
Number · correlation coefficient
Correlation Between Penn Spasm Frequency Scale and Insulin Resistance
correlation coefficientMotor Complete GroupMotor Incomplete Group
Correlation Between Penn Spasm Frequency Scale and Insulin Resistance0.354-0.002
Statistical analysis
  • Motor Complete Group · Pearson correlation test · p = 0.214
  • Motor Incomplete Group · Pearson correlation test · p = 0.993 (p\<0.05 was considered statisticaly significant.)
PrimaryCorrelation Between Penn Spasm Frequency Scale and Insulin Sensitivity

We used the Matsuda index to assess insulin sensitivity. Matsuda index was calculated 10.000/square root (Fasting plasma glucose x fasting plasma insulin) x (mean OGTT glucose concentration X mean OGTT insulin concentration) formula. Higher scores mean better. Penn Spasm Frequency Scale is used to assess spasms. This scale is a 5-point scale. Higher scores mean a worse outcome. Pearson correlation was used to calculate the correlation coefficient (r).

Time frame:
One day
Reported as:
Number · correlation coefficient
Correlation Between Penn Spasm Frequency Scale and Insulin Sensitivity
correlation coefficientMotor CompleteMotor Incomplete
Correlation Between Penn Spasm Frequency Scale and Insulin Sensitivity0.289-0.103
Statistical analysis
  • Motor Complete · Pearson correlation test · p = 0.41
  • Motor Incomplete · Pearson correlation test · p = 0.676
PrimaryCorrelation Between Knee Flexor Muscle Modified Ashworth Scale and Total Body Fat-Free Mass%

The body composition of the individuals was measured by dual-energy absorptiometry (DXA) device. Modified Ashworth Scale is used to assess muscle spasticity on a 6-point scale. 0: No increase in muscle tone 4: Affected part(s) is (are) rigid in flexion or extension. Higher scores mean a worse outcome. Pearson correlation was used to calculate correlation coefficient.

Time frame:
One day
Reported as:
Number · correlation coefficient
Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Total Body Fat-Free Mass%
correlation coefficientMotor CompleteMotor Incomplete
Correlation Between Knee Flexor Muscle Modified Ashworth Scale and Total Body Fat-Free Mass%0.2010.287
Statistical analysis
  • Motor Complete · Pearson correlation test · p = 0.511 (p\<0.05 was considered statisticaly significant.)
  • Motor Incomplete · Pearson correlation test · p = 0.248
PrimaryCorrelation Between Penn Spasm Frequency Scale and Total Body Fat-Free Mass%

The body composition of the individuals was measured by dual-energy absorptiometry (DXA) device. Penn Spasm Frequency Scale is used to assess spasms. This scale is a 5-point scale. Higher scores mean a worse outcome. Pearson correlation was used to calculate the correlation coefficient (r).

Time frame:
One day
Reported as:
Number · correlation coefficient
Correlation Between Penn Spasm Frequency Scale and Total Body Fat-Free Mass%
correlation coefficientMotor CompleteMotor Incomplete
Correlation Between Penn Spasm Frequency Scale and Total Body Fat-Free Mass%-0.1380.526
Statistical analysis
  • Motor Complete · Pearson correlation test · p = 0.654
  • Motor Incomplete · Pearson correlation test · p = 0.025

Adverse events

Collected over One day. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Motor Complete0/14 (0%)0/14 (0%)0/14 (0%)
Motor Incomplete0/19 (0%)0/19 (0%)0/19 (0%)

Baseline characteristics

ASIA impairment scale (AIS) is the most prominent standardized clinical grading and classification method for the assessment of patients with spinal cord injury (SCI). Patients with AIS A and B are motor complete group, AIS C and D are motor incomplete group.

Age, Categorical
Age, Categorical(Participants)Motor Complete GroupMotor Incomplete GroupTotal
<=18 years000
Between 18 and 65 years141933
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Motor Complete GroupMotor Incomplete GroupTotal
Female7411
Male71522
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Motor Complete GroupMotor Incomplete GroupTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White141933
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)Motor Complete GroupMotor Incomplete GroupTotal
Turkey141933
Time since injury
Time since injury(months)Motor Complete GroupMotor Incomplete GroupTotal
Mean47.4 ± 52.662.1 ± 47.855.85 ± 49.63
08

Study locations

No study locations are listed for this record.

09

References and documents

Publications

  • Skold C, Levi R, Seiger A. Spasticity after traumatic spinal cord injury: nature, severity, and location. Arch Phys Med Rehabil. 1999 Dec;80(12):1548-57. doi: 10.1016/s0003-9993(99)90329-5. PubMed 10597805 ↗
  • Gorgey AS, Dudley GA. Spasticity may defend skeletal muscle size and composition after incomplete spinal cord injury. Spinal Cord. 2008 Feb;46(2):96-102. doi: 10.1038/sj.sc.3102087. Epub 2007 Jul 17. Erratum In: Spinal Cord. 2008 Dec;46(12):825. PubMed 17637764 ↗
  • Gorgey AS, Dolbow DR, Dolbow JD, Khalil RK, Castillo C, Gater DR. Effects of spinal cord injury on body composition and metabolic profile - part I. J Spinal Cord Med. 2014 Nov;37(6):693-702. doi: 10.1179/2045772314Y.0000000245. Epub 2014 Jul 7. PubMed 25001559 ↗
  • Gorgey AS, Dudley GA. Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury. Spinal Cord. 2007 Apr;45(4):304-9. doi: 10.1038/sj.sc.3101968. Epub 2006 Aug 29. PubMed 16940987 ↗
  • Gorgey AS, Chiodo AE, Zemper ED, Hornyak JE, Rodriguez GM, Gater DR. Relationship of spasticity to soft tissue body composition and the metabolic profile in persons with chronic motor complete spinal cord injury. J Spinal Cord Med. 2010;33(1):6-15. doi: 10.1080/10790268.2010.11689669. PubMed 20397439 ↗
  • Jung IY, Kim HR, Chun SM, Leigh JH, Shin HI. Severe spasticity in lower extremities is associated with reduced adiposity and lower fasting plasma glucose level in persons with spinal cord injury. Spinal Cord. 2017 Apr;55(4):378-382. doi: 10.1038/sc.2016.132. Epub 2016 Sep 13. PubMed 27618974 ↗

Study documents

  • Study protocol · Aug 6, 2020
  • Statistical analysis plan · Aug 6, 2020
  • Informed consent form · Aug 6, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03859960
Lead sponsor
Fatih Sultan Mehmet Training and Research Hospital
Responsible party
Arzu Atici (Principal Investigator, Fatih Sultan Mehmet Training and Research Hospital) — Principal investigator
First posted
Mar 1, 2019
Start date
Sep 21, 2014
Primary completion
May 10, 2018
Completion
Aug 8, 2018
Results posted
Sep 4, 2020
Last update
Sep 4, 2020

Study contacts

Arzu Atici
principal investigator · Fatih Sultan Mehmet Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion